MEDICINE

UK’s First Birth Following Living-donor Uterine Transplantation

The woman who had undergone the first living-donor uterus transplantation (LD UTx) in the UK earlier in 2023 for absolute uterine factor infertility (AUFI)...

Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  

Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has received FDA approval. It is a small interfering RNA (siRNA) based therapeutic that interfere with natural anticoagulants such as...

Titanium Device as a Permanent Replacement for a Human Heart  

Use of “BiVACOR Total Artificial Heart”, a titanium metal device has enabled the longest successful bridge to heart transplant lasting over three months. The...

Robotic Surgery: First Fully Robotic Double Lung Transplant Performed  

On October 22, 2024, a surgical team performed the first fully robotic double lung transplant on a 57-year-old woman with chronic obstructive pulmonary disease...

Asciminib (Scemblix) for Newly Diagnosed Chronic Myeloid Leukemia (CML)  

Asciminib (Scemblix) has been approved for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). The accelerated approval...

Hympavzi (marstacimab): New Treatment for Hemophilia

On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...

Cobenfy (KarXT): A More Atypical Antipsychotic for Treatment of Schizophrenia

Cobenfy (also known as KarXT), a combination of the drugs xanomeline and trospium chloride, has been studied to be effective for the treatment of...

First UK Lung Cancer Patient receives mRNA vaccine BNT116  

BNT116 and LungVax are nucleic acid lung cancer vaccine candidates – the former is based on mRNA technology similar to “COVID-19 mRNA vaccines” such...

Lecanemab for Early Alzheimer’s Disease approved in the UK but refused in EU 

Monoclonal antibodies (mAbs) lecanemab and donanemab have been approved for the treatment of early Alzheimer’s disease in the UK and USA respectively while lecanemab...

Mpox Disease: The Antiviral Tecovirimat (TPOXX) Found Ineffective in Clinical Trial

The monkeypox virus (MPXV), called so because of its first discovery in monkeys kept in research facility in Denmark, is closely related to variola...

Monkeypox (Mpox) Outbreak Declared A Public Health Emergency of International Concern 

The upsurge of mpox in the Democratic Republic of the Congo (DRC) and in many other countries in Africa has been determined by WHO...

Stay in touch:

92,115FansLike
45,578FollowersFollow
1,772FollowersFollow

Newsletter

Don't miss

Aviptadil Could Reduce Mortality Among Severely Ill COVID Patients

In June 2020, RECOVERY trial from a group of...

A Hopeful Alternative to Antibiotics for Treating Urinary Tract Infections

Researchers have reported a new way to treat Urinary...

Tricking the Body: a New Preventive Way to Tackle Allergies

A new study shows an innovative method to tackle...

A Broad-Spectrum Antiviral Drug Candidate

Recent study has developed a new potential broad-spectrum drug...

A New Non-Addictive Pain-relieving Drug

Scientists have discovered a safe and non-addictive synthetic bifunctional...